Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis

NCT02133664 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis
Cognition

Interventions

DRUG: lipoic acid and omega-3 fatty acids
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]